Clinical Trial Update: Amino Acid Tracer (FACBC) Positron Emission Tomography for Lung Nodule [Phase 1]

View source ↗

Summary

Emory University reports completion of a Phase 1 study evaluating the amino acid PET tracer FACBC (18F-FACBC) for imaging lung nodules in suspected lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• FACBC (18F-FACBC) PET tracer (18F-FACBC)

Snippet

Sponsor: Emory University | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED